Status:

RECRUITING

CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)

Lead Sponsor:

Russian Society of Colorectal Surgeons

Conditions:

Colonic Neoplasms

Eligibility:

All Genders

Phase:

PHASE3

Brief Summary

In general, the European pathological examination method primarily relies on pathologists and does not require the involvement of surgeons. The Japanese pathological evaluation approach, on the other ...

Eligibility Criteria

Inclusion

  • Patients diagnosed with colon cancer who underwent colectomy;
  • Patients with pathological confirmed adenocarcinoma;
  • Patients agreed to participate in the study.

Exclusion

  • Patients suffered from rectal cancer;
  • Patients diagnosed with colon cancer but did not undergo colectomy;
  • Patients refused participation.

Key Trial Info

Start Date :

November 14 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

430 Patients enrolled

Trial Details

Trial ID

NCT06119867

Start Date

November 14 2023

End Date

December 1 2025

Last Update

April 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinic of coloproctology and minimally invasive surgery

Moscow, Russia

CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE) | DecenTrialz